Showing results (91-100 of 502) with videos related to

Sort By:
Pageof 51
Neurology. Clinical Practice|November 16, 2022
Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple SclerosisYinan Zhang, Stacey Cofield, Gary Cutter, et al.
Rheumatology (Oxford, England)|April 11, 2021
Intensive and app-delivered occupational therapy to improve upper extremity function in early diffuse cutaneous systemic sclerosis: a pilot two-arm trialSusan L Murphy, Mary Barber, Suiyuan Huang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2023
The impact of relapse definition and measures of durability on MS clinical trial outcomesSammita Satyanarayan, Gary Cutter, Stephen Krieger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Validation of the NARCOMS registry: fatigue assessmentRuth Ann Marrie, Gary Cutter, Tuula Tyry, et al.
The Lancet. Neurology|March 17, 2015
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectivesDaniel Ontaneda, Robert J Fox, Jeremy Chataway
Multiple Sclerosis and Related Disorders|April 21, 2015
Natalizumab reduces relapse clinical severity and improves relapse recovery in MSFred D Lublin, Gary Cutter, Gavin Giovannoni, et al.
The Journal of Infectious Diseases|October 22, 2024
Neutralizing Antibody Responses to Chlamydia trachomatis in Women and Associations With Chlamydia OutcomesHong Yu, William M Geisler, Chuanbin Dai, et al.
Multiple Sclerosis and Related Disorders|April 21, 2019
Evaluation of a web-based fall prevention program among people with multiple sclerosisMeena Kannan, Andrea Hildebrand, Cinda L Hugos, et al.
Muscle & Nerve|June 8, 2022
One-year follow-up of disease burden and medication changes in patients with myasthenia gravis: From the MG Patient RegistryIkjae Lee, Justin M Leach, Inmaculada Aban, et al.
Neurology|July 10, 2013
Mortality in patients with multiple sclerosisAntonio Scalfari, Volker Knappertz, Gary Cutter, et al.
Pageof 51